Thermo Fisher buys lab-tests maker
Thermo Fisher Scientific Inc., a Waltham company that sells laboratory equipment and analytical instruments, reported that it has acquired TREK Diagnostic Systems, an Ohio company that makes blood culture, microorganism identification, and other testing products.
The seller was Magellan Biosciences.
TREK’s product line complements Thermo Fisher’s portfolio of microbiological testing technologies, Thermo Fisher said.
It did not release financial details of the transaction but noted that TREK had 2010 revenue of $34 million and has 150 employees.
Thermo Fisher, with annual revenue of roughly $11 billion, employs approximately 37,000 people.
The company in May disclosed plans to pay $3.5 billion for a Swedish diagnostics company, Phadia AB, in its largest buyout ever.
And last year, Thermo Fisher Scientific said that it would pay about $2.1 billion to buy Dionex Corp., a California company that makes chromatography equipment for things like drug manufacturing and testing drinking water for contaminants.